48 Participants Needed

Cranberry Juice for Preventing UTIs

LG
YY
Overseen ByYavuz Yagiz, PhD
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: University of Florida
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 3 JurisdictionsThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

The investigators pre-preliminary study showed that the urine from a portion of study participants had anti-adhesion activity. The investigators propose that UTI susceptible women can be divided into responders and non-responders depending on whether cranberry intake increase anti-adhesion activity of their urine. The overall objectives are to identify gut microbes and anti-adhesive urinary biomarkers which significantly contribute to the anti-adhesion of E. coli.

Do I need to stop my current medications to join the trial?

Yes, you may need to stop taking medications that could influence the study's outcome.

Will I have to stop taking my current medications?

The trial excludes participants who take medications that might influence the study's outcome, so you may need to stop certain medications. It's best to discuss your current medications with the trial team to see if they are allowed.

What data supports the idea that Cranberry Juice for Preventing UTIs is an effective treatment?

The available research shows that cranberry juice and extracts can help prevent urinary tract infections (UTIs), especially in women with recurrent UTIs. One study found that cranberry extract with a high content of a specific compound (PAC-A) was effective in preventing UTIs. Another study showed that cranberry extract reduced the recurrence of UTIs in young people with a history of these infections. A meta-analysis, which combined results from 23 trials with nearly 4,000 participants, found that cranberry products significantly lowered the chance of getting UTIs in people who are more likely to have them. This suggests that cranberry juice can be a helpful treatment for preventing UTIs.12345

What data supports the effectiveness of cranberry juice as a treatment for preventing UTIs?

Research shows that cranberry juice and extracts, which contain compounds called proanthocyanidins, can help prevent urinary tract infections (UTIs) by stopping bacteria from sticking to the urinary tract. Studies have found that cranberry products can significantly reduce the incidence of UTIs, especially in people who are prone to them.12345

What safety data is available for cranberry juice in preventing UTIs?

Cranberry juice and extracts, particularly those containing A-type proanthocyanidins, are widely used for preventing urinary tract infections (UTIs). Clinical trials and studies have shown that cranberry products are generally safe, with no adverse events or side effects reported in trials involving both children and adults. The use of cranberry products also provides additional health benefits, such as antioxidant and cholesterol-lowering effects. However, the effectiveness and safety can vary due to differences in product composition and standardization.12467

Is cranberry juice safe for preventing urinary tract infections?

Cranberry juice and extracts, including those with high proanthocyanidin content, are generally considered safe for human use, with no adverse effects reported in studies involving both children and adults.12467

Is cranberry juice a promising treatment for preventing UTIs?

Yes, cranberry juice is a promising treatment for preventing UTIs. It contains special compounds called proanthocyanidins that stop bacteria from sticking to the urinary tract, which helps prevent infections. Studies have shown that cranberry juice can be effective, especially for women with recurring UTIs, and it also offers additional health benefits like antioxidant and cholesterol-lowering effects.12348

How is cranberry juice different from other treatments for preventing UTIs?

Cranberry juice is unique because it contains proanthocyanidins (PACs) that prevent bacteria from sticking to the urinary tract, which is different from antibiotics that kill bacteria. This natural anti-adhesion mechanism is also being explored for other bacterial conditions, and cranberry products are generally safe with added benefits like antioxidant and cholesterol-lowering effects.12348

Research Team

LG

Liwei Gu, PhD

Principal Investigator

University of Florida

YY

Yavuz Yagiz, PhD

Principal Investigator

University of Florida

Eligibility Criteria

This trial is for healthy women who are prone to urinary tract infections (UTIs). Participants should weigh at least 110 pounds with a BMI between 18.5-29.9 kg/m2. Women who are pregnant, breastfeeding, have significant health issues, take medications that could affect the study's outcome, or have a BMI of 30 or higher cannot join.

Inclusion Criteria

Your body mass index (BMI) is within a healthy range.
I am a healthy woman.
I weigh at least 110 pounds.

Exclusion Criteria

Pregnancy and breast-feeding
You are a regular smoker or consume alcohol frequently.
History of any clinically important disorder that may interfere with interpretation of the results
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants consume cranberry or placebo juice for 21 days to assess changes in urinary anti-adhesion activity and gut microbiomes

3 weeks
Baseline and end of 21 days

Follow-up

Participants are monitored for changes in urinary biomarkers and gut microbiomes after treatment

4 weeks

Treatment Details

Interventions

  • Cranberry Juice
  • Placebo Juice
Trial OverviewThe study is testing if drinking cranberry juice can prevent UTIs in women likely to get them by increasing urine's anti-adhesion properties against E. coli bacteria. It will also identify gut microbes and biomarkers related to this effect.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Placebo juice consumptionExperimental Treatment1 Intervention
Participants will be provided placebo juice to consume for 21 days
Group II: Experimental: Cranberry juice consumptionExperimental Treatment1 Intervention
Participants will be provided cranberry juice to consume for 21 days

Cranberry Juice is already approved in United States, European Union, Canada for the following indications:

🇺🇸
Approved in United States as Cranberry Juice for:
  • Urinary Tract Infection (UTI) prophylaxis
🇪🇺
Approved in European Union as Cranberry Juice for:
  • Urinary Tract Infection (UTI) prophylaxis
🇨🇦
Approved in Canada as Cranberry Juice for:
  • Urinary Tract Infection (UTI) prophylaxis

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Florida

Lead Sponsor

Trials
1,428
Recruited
987,000+

Findings from Research

The study demonstrated that a cranberry extract called Oximacro, containing 36 mg of proanthocyanidins A (PAC-A), significantly reduced urinary tract infection (UTI) occurrences in both male and female volunteers after 7 days of administration.
Accurate measurement of PAC content is crucial for UTI prevention, as the study confirmed that Oximacro's high PAC-A content led to significant differences in UTI prevention compared to a placebo, highlighting its potential as an effective preventive treatment.
Prevention of Urinary Tract Infection with Oximacro, A Cranberry Extract with a High Content of A-Type Proanthocyanidins: A Pre-Clinical Double-Blind Controlled Study.Occhipinti, A., Germano, A., Maffei, ME.[2020]
Cranberry (Vaccinium macrocarpon) has been shown to help prevent recurrent urinary tract infections (UTIs) in women by inhibiting the adhesion of E. coli bacteria to the bladder, thanks to specific compounds called proanthocyanidins (PAC).
Cranberry is a safe and well-tolerated supplement with no significant drug interactions, and while research is still in early stages, it may also offer additional health benefits such as anti-infective, anticancer, and antioxidant effects, as well as potential positive impacts on cardiovascular and metabolic health.
Vaccinium macrocarpon: an interesting option for women with recurrent urinary tract infections and other health benefits.Pérez-López, FR., Haya, J., Chedraui, P.[2009]
In a study involving 36 healthy adolescents aged 12 to 18 with recurrent urinary tract infections (UTIs), those who took a daily supplement of standardized cranberry extract (Anthocran®) experienced a significant reduction in UTIs, averaging 0.31 infections compared to 2.3 in the control group.
The cranberry extract also led to a higher percentage of symptom-free participants (63.1% in the supplementation group vs. 23.5% in the control group), demonstrating its potential as an effective prophylactic treatment for recurrent UTIs.
Highly standardized cranberry extract supplementation (Anthocran®) as prophylaxis in young healthy subjects with recurrent urinary tract infections.Ledda, A., Belcaro, G., Dugall, M., et al.[2018]

References

Prevention of Urinary Tract Infection with Oximacro, A Cranberry Extract with a High Content of A-Type Proanthocyanidins: A Pre-Clinical Double-Blind Controlled Study. [2020]
Vaccinium macrocarpon: an interesting option for women with recurrent urinary tract infections and other health benefits. [2009]
Highly standardized cranberry extract supplementation (Anthocran®) as prophylaxis in young healthy subjects with recurrent urinary tract infections. [2018]
Cranberry juice for prophylaxis of urinary tract infections--conclusions from clinical experience and research. [2013]
Consumption of cranberry as adjuvant therapy for urinary tract infections in susceptible populations: A systematic review and meta-analysis with trial sequential analysis. [2021]
Comprehensive assessment of the quality of commercial cranberry products. Phenolic characterization and in vitro bioactivity. [2012]
Cranberries for Preventing Recurrent Urinary Tract Infections in Uncircumcised Boys. [2017]
Comparison of the Anti-Adhesion Activity of Three Different Cranberry Extracts on Uropathogenic P-fimbriated Escherichia coli: a Randomized, Double-blind, Placebo Controlled, Ex Vivo, Acute Study. [2022]